WO2009018368A1 - Combination treatment of nmda (n-methyl-d-aspartate)-enhancer, glycine transporter inhibitor, d-amino acid oxidase inhibitor (daaoi) for neuropsychiatric disorders - Google Patents

Combination treatment of nmda (n-methyl-d-aspartate)-enhancer, glycine transporter inhibitor, d-amino acid oxidase inhibitor (daaoi) for neuropsychiatric disorders Download PDF

Info

Publication number
WO2009018368A1
WO2009018368A1 PCT/US2008/071632 US2008071632W WO2009018368A1 WO 2009018368 A1 WO2009018368 A1 WO 2009018368A1 US 2008071632 W US2008071632 W US 2008071632W WO 2009018368 A1 WO2009018368 A1 WO 2009018368A1
Authority
WO
WIPO (PCT)
Prior art keywords
yl
phenyl
acid
methyl
propyl
Prior art date
Application number
PCT/US2008/071632
Other languages
French (fr)
Inventor
Guochuan Emil Tsai
Original Assignee
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US95282807P priority Critical
Priority to US60/952,828 priority
Application filed by Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center filed Critical Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center
Publication of WO2009018368A1 publication Critical patent/WO2009018368A1/en

Links